Boston, MA -- (SBWIRE) -- 09/12/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: (Galectin Therapeutics Inc. (NASDAQ:GALT), Glu Mobile Inc.(NASDAQ:GLUU), Galena Biopharma Inc (NASDAQ:GALE), FalconStor Software, Inc. (NASDAQ:FALC)
Galectin Therapeutics Inc. (NASDAQ:GALT) shares gained 26.60% to $10.85. The company on Sept. 10 announced that it has received a notice of issuance from the U.S. Patent and Trademark Office for Patent Application Number 13/573,454 titled "Galacto-rhamnogalacturonate compositions for the treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease." The patent covers the Company's carbohydrate-based galectin inhibitor compound GR-MD-02 for use in patients with fatty liver disease with or without fibrosis or cirrhosis. Fatty liver disease affects as many as 15 million Americans, results in severe scarring of the liver (cirrhosis), and there are no currently approved pharmaceutical therapies.
How Should Investors Trade GALT After The Recent Volatility? Get Free Report Here
Glu Mobile Inc.(NASDAQ:GLUU)sares decreased 0.41% to $2.41. The company on Sept. 11 announced its intention to offer shares of its common stock in an underwritten public offering. Glu expects to grant the underwriters a 30-day option to purchase up to an additional 15 percent of the shares of common stock offered in the public offering to cover over-allotments, if any. The offering is subject to customary conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
How Should Investors Trade GLUU After The Recent Volatility? Get Free Report Here
Galena Biopharma Inc (NASDAQ:GALE) shares increased 3.48% to $2.38. The company on August 21 announced the European Patent Office notified the Company of an intention to grant a Pharmaceutical Use Patent for NeuVax(TM) (nelipepimut-S). The patent covers the use of NeuVax as a vaccine for the prevention of relapse in breast cancer patients with an immunochemistry (IHC) rating of 1+ or 2+ for HER2/neu protein expression and a fluorescence in situ hybridization (FISH) rating of less than 2.0 for HER2/neu gene expression. The patent protection is afforded in all of the European countries and will expire in April 2028.
Is GALE A Good Buy After The Recent Price Movement? Find Out Here
FalconStor Software, Inc. (NASDAQ:FALC) shares climbed 18.27% and closed at $1.23. The company on August 19 announced that the latest version of its FalconStor® Continuous Data Protector (CDP) and FalconStor® Network Storage Server (NSS) data protection solutions with RecoverTrac™ disaster recovery (DR) automation technology now offer enhanced features for intelligently moving, storing, protecting and analyzing data without burdening production resources. The RecoverTrac tool now has more flexibility to automate failover and failback with greater accuracy in any physical, virtual or hybrid environment, including VMware and Hyper-V deployments.
Is FALC A Strong Buy? Get Advantage Of Our Free Trend Analysis Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t sure you won’t be disappointed.
http://winstonsmallcap.com/and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)